Gelonghui, March 4, 丨 Paulette (300246.SZ) announced that the company held the 13th meeting of the 8th board of directors on March 4, 2024 to review and pass the “Proposal on Internal Transfer of Subsidiary Shares”. The board of directors agreed that in order to further optimize the company's management structure, improve business management and operation efficiency, and reduce management costs, the company plans to integrate subsidiaries related to the blood purification consumables business in Tianjin to develop medical devices owned by the wholly-owned subsidiary Tianjin Baolite Technology Co., Ltd. (hereinafter referred to as “Tianjin Medical Baolite”) 40% of the shares of the limited company (hereinafter referred to as “Tianjin Zhishin”) were transferred free of charge to the company. After the transfer is completed, the company will hold 100% of Tianjin Zhishin's shares.
宝莱特(300246.SZ)：拟内部划转子公司股权
Paulette (300246.SZ): Proposed internal transfer of subsidiary shares
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.